ENvue Medical (FEED) Net Income towards Common Stockholders (2014 - 2026)
ENvue Medical (FEED) posted quarterly Net Income towards Common Stockholders of -$22.6 million for Q1 2026, down 1108.39% year-over-year from $2.2 million in Q1 2025, and down 66.05% quarter-over-quarter from -$13.6 million in Q4 2025.
ENvue Medical (FEED) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Net Income towards Common Stockholders for 13 consecutive years, with -$22.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 1108.39% year-over-year to -$22.6 million; the TTM figure through Mar 2026 stood at -$37.5 million (down 652.13% YoY), while the FY2025 annual figure was -$16.8 million, down 352.77% from the prior year.
- Net Income towards Common Stockholders eased to -$22.6 million in Q1 2026 per FEED's latest filing, from -$13.6 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$500000.0 in Q2 2025 and bottomed at -$22.6 million in Q1 2026.
- Historically, Net Income towards Common Stockholders has averaged -$3.1 million across 5 years, with a median of -$1.1 million in 2023.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders jumped 85.69% — and 2026, when it slumped 1108.39%.
- ENvue Medical's Net Income towards Common Stockholders stood at -$2.1 million in 2022, then jumped by 60.51% to -$813000.0 in 2023, then sank by 76.01% to -$1.4 million in 2024, then plunged by 851.99% to -$13.6 million in 2025, then slumped by 66.05% to -$22.6 million in 2026.
- Business Quant data shows FEED's Net Income towards Common Stockholders at -$22.6 million in Q1 2026, -$13.6 million in Q4 2025, and -$780000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.93 Bn | 123.46 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.40 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.69 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 201.00 Mn |
| 10 | ENvue Medical | 2.49 Mn | 1.35 Mn | -266,000.00 | -12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.16 Mn |
| Mar 31, 2026 | -22.62 Mn |
| Dec 31, 2025 | -13.62 Mn |
| Sep 30, 2025 | -780,000.00 |
| Jun 30, 2025 | -500,000.00 |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | -1.43 Mn |
| Sep 30, 2024 | -998,000.00 |
| Jun 30, 2024 | -688,000.00 |
| Mar 31, 2024 | -588,000.00 |
| Dec 31, 2023 | -813,000.00 |
| Sep 30, 2023 | -727,000.00 |
| Jun 30, 2023 | -1.07 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -2.06 Mn |
| Sep 30, 2022 | -955,000.00 |
| Jun 30, 2022 | -1.30 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | -2.47 Mn |
| Sep 30, 2021 | -6.67 Mn |